Tag: Acute Lymphoblastic Leukemia
Therapeutic drug monitoring of methotrexate in disease
Professor Dr Robert de Jonge, Dr Gerrit Jansen, Ittai Muller MSc and Helen Gosselt MSc, Amsterdam University Medical Center, are pioneering analytical approaches which can be used to understand why patients respond differently to the anchor drug used to manage rheumatoid arthritis, called methotrexate. Their work has begun to unravel the key factors behind the mechanism of action of methotrexate, […]
Read More… from Therapeutic drug monitoring of methotrexate in disease